Tourmaline Bio, Inc.
TRML · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,092 | -$22,970 | -$22,235 | -$20,177 |
| Dep. & Amort. | $12 | $12 | $9 | $10 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,466 | $2,273 | $1,735 | $1,681 |
| Change in WC | $0 | $526 | $1,534 | $1,843 |
| Other Non-Cash | $350 | -$1,520 | -$1,932 | -$6,801 |
| Operating Cash Flow | -$20,264 | -$21,679 | -$20,889 | -$23,444 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$9 | -$9 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$40,454 | -$85,164 | -$19,691 | -$88,045 |
| Inv. Sales/Matur. | $56,764 | $111,114 | $36,090 | $76,350 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $16,303 | $25,941 | $16,390 | -$11,695 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $569 | $0 | $0 |
| Stock Repurch. | $0 | -$7 | -$3 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $54 | $0 | $0 | $0 |
| Financing Cash Flow | $54 | $562 | -$3 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,907 | $4,824 | -$4,502 | -$35,140 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,557 | $30,733 | $35,235 | $70,148 |
| End Cash | $31,650 | $35,557 | $30,733 | $35,235 |
| Free Cash Flow | -$20,271 | -$21,688 | -$20,898 | -$23,444 |